G. V. M. Sharma et al. / Tetrahedron Letters 47 (2006) 6537–6540
6539
O
R
O
R
(CH2)3-OBn
12 (43%)
a, b
c
d
7
OBn
(CH2)3-OBn
11 (80%)
9 R = H (94%)
+
10 R = allyl (77%)
OH
HO
(CH2)3-OBn
13 (40%)
O
OTPSOH
( )
O
OR
OTPS
i, g
e, f
R
g, h
OBn
N
O
12
5
S
OR
6 R = CH2OH (92%)
16 R = CHO (95%)
14 R = H (96%)
15 R = OTPS (97%)
Bn
17 R = PMB (65%)
18 R = H (92%)
OR'
( )
OTPS
O
OTPS
( )
O
R
l,m,n
CO2R
j
5O
k, h
( )
5O
O
N
O
5O
O
O
21 R = Me, R' = TPS (80%)
22 R = H, R' = TPS (85%)
4 R = R' = H (75%)
Bn
5 R = CH2OH (79%)
20 R = CHO (92%)
19 (85%)
OH
OH
p or q
O
OH
o
S
S
+
S
O
O
O
O
O
O
OH
3
O
O
O
23 (66%)
1
N
O
BMPO
(R)-chiral auxiliary =
Ph
I
Scheme 2. Reagents and conditions: (a) NaH, BnBr, THF, 0 ꢁC–rt, 5 h; (b) allyl bromide, CuI, K2CO3 and TBAI, DMF, rt, 12 h; (c) m-CPBA,
CH2Cl2, rt, 10 h; (d) R,R-Jacobsen’s catalyst, H2O, rt, 12 h; (e) LAH, THF, 0 ꢁC–rt, 5 h; (f) TBDPSCl, imidazole, CH2Cl2, 0 ꢁC–rt, 3 h; (g) 10% Pd/
C, MeOH, H2, 12 h; (h) IBX, DMSO, 0 ꢁC–rt, 5 h; (i) (R)-chiral auxiliary (I), Bu2BOTf, DIPEA, CH2Cl2, 0–78 ꢁC, 4 h; (j) 2,2-DMP, CSA, 0 ꢁC–rt,
30 min; (k) LiBH4, THF–H2O (2:1), 0 ꢁC–rt, 3 h; (l) Ph3P@CHCOOMe, MeOH, 0 ꢁC–rt, 2 h; (m) 4 N NaoH, MeOH, 0 ꢁC–rt, 4 h; (n) HF–pyridine,
THF, 0 ꢁC–rt, 12 h; (o) 2,4,6-trichlorobenzoyl chloride, THF, Et3N, 0 ꢁC–rt, 8 h, DMAP, toluene, reflux, 20 h; (p) TiCl4, CH2Cl2, 0 ꢁC–rt, 2 h, 85%
exclusive 1; (q) 80% AcOH, rt, 12 h, 3, in 20% and 1 in 52%.
OR'
a, b, c
S
d
S
O
O
S
S
OH
OH
CO2R
e
20
(
)
5
S
O
O
S
O
O
O
O
24 R = Me, R' = TPS (85%)
25 R = H, R' = TPS (80%)
8 R = R' = H (75%)
26 (57%)
2 (85%)
Scheme 3. Reagents and conditions: (a) Ph3P@CHCOOMe, toluene, reflux, 4 h; (b) 4 N NaOH, MeOH, 0 ꢁC–rt, 4 h; (c) HF–pyridine, THF, 0 ꢁC–rt,
12 h; (d) 2,4,6-trichlorobenzoyl chloride, THF, Et3N, 0 ꢁC–rt, 8 h, DMAP, toluene, reflux, 20 h; (e) TiCl4, CH2Cl2, 0 ꢁC–rt, 2 h.
(75 MHz, CDCl3): d 19.6, 21.5, 24.6, 25.8, 30.5, 32.3,
68.1, 73.8, 74.5, 121.5, 149.0, 166.8; IR (KBr): 1075,
1282, 1350, 1635, 1715, 2940, 3320 cmÀ1; ESIMS:
(m/z, %): 229 (M++1, 35), 167 (58), 149 (24), 109
(100); HRMS (ESI): m/z calcd for C12H21O4 [M+H]+
229.1439, found 229.1436.
3.0 Hz, H-3); 13C NMR (75 MHz, CDCl3): d 20.5,
24.2, 24.5, 27.4, 32.1, 34.4, 74.3, 76.6, 77.8, 124.2,
145.6, 166.2; IR (KBr): 850, 1170, 1265, 1635, 1710,
2925, 3518 cmÀ1; FABMS: (m/z, %): 251 (M++23, 12),
187 (94), 151 (26), 127 (100), 55 (44); HRMS (FABMS):
m/z calcd for C12H21O4 [M+H]+ 229.1439, found
229.1432.
2.2. Cladospolide-C (2)
2.3. iso-Cladospolide-B (3)
Colourless solid, mp 90–92 ꢁC; (lit.1 mp 90–91 ꢁC); [a]D
+45.9 (c 0.4, CHCl3); lit.1 [a]D +59.7 (c 0.4, MeOH); 1H
NMR (300 MHz, CDCl3): d 1.25 (d, 3H, J = 6.0 Hz, H-
12), 1.15–1.90 (m, 10H, 5 · CH2), 3.45–3.57 (m, 1H, H-
5), 4.15–4.22 (m, 1H, H-4), 5.15–5.25 (m, 1H, H-11),
6.12 (d, 1H, J = 14.9 Hz, H-2), 7.08 (dd, 1H, J = 14.9,
Colourless syrup, [a]D À59.6 (c 0.3, CHCl3); (lit.5 [a]D
1
À61.0 (c 16.6, MeOH)); H NMR (500 MHz, CDCl3):
d 1.19 (d, 3H, J = 5.8 Hz, H-12), 1.22–1.61 (m, 10H,
5 · –CH2), 3.70 (m, 1H, H-11), 3.77 (m, 1H, H-5),
4.97 (q, 1H, J = 1.8 Hz, H-4), 6.18 (dd, 1H, J = 5.8,